Why Nektar Therapeutics Shares Are Soaring 13% Higher
After the company reported third-quarter earnings that were better than industry watchers' forecasts, shares in Nektar Therapeutics (NASDAQ: NKTR) are popping 13.1% higher today as of 2:45 p.m. EST.
Nektar Therapeutics' third-quarter top- and bottom-line figures came in ahead of analysts' forecasts. The company's sales increased $152.9 million from $36.3 million in the third quarter of 2016, and its net income of $60.9 million, or $0.39 per share, marked a big improvement from its net loss of $43.2 million, or $0.32 in the same quarter of 2016.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Nektar Therapeutics Aktie
1,02 €
0,69 %
Nektar Therapeutics sticht etwas positiv hervor mit 4 Buy- und 1 Sell-Einschätzungen.
Das Kursziel von 2 € für Nektar Therapeutics bedeutet eine deutliche Steigerung von über 50% gegenüber dem aktuellen Kurs von 1.02 €.
